Results With CAPLYTA® (lumateperone) Skip to Main Content For US Residents Only Visit US Healthcare Professionals Site Download Brochure Important Safety Information Prescribing Information Medication Guide Other Indications Important Safety Information Prescribing Information Medication Guide Cost & Savings Close Menu About Bipolar Depression About CAPLYTA CAPLYTA Results Taking CAPLYTA Common Side Effects Tools & Resources Helpful Tools Additional Resources Real Patient Videos Ask About CAPLYTA Cost & Savings Cost & Savings Download Brochure For US Residents only Visit US Healthcare Professionals Site Other Indications About Bipolar Depression About CAPLYTA CAPLYTA Results Taking CAPLYTA Common Side Effects Tools & Resources Helpful Tools Additional Resources Real Patient Videos Ask About CAPLYTA Cost & Savings Cost & Savings CAPLYTA Results Rise above the lows In the darkness of bipolar I or II depression, CAPLYTA can help you let in the LYTE. Actor portrayals. CAPLYTA is proven to provide significant relief from depressive symptoms of bipolar disorder in adults at 6 weeks Studies have also shown CAPLYTA can reduce the overall severity of bipolar depression at 6 weeks Unlike some medications that only treat bipolar I, CAPLYTA treats both bipolar I and bipolar II depression and can be taken alone or with lithium or valproate How does CAPLYTA work? CAPLYTA is a once-daily capsule that's believed to work by affecting chemicals in the brain that are involved in mood, including serotonin and dopamine. The exact way CAPLYTA works is not fully understood. Ask your healthcare provider about CAPLYTA to see if it's right for you Use this interactive tool to build a personalized discussion guide you can bring to your next appointment. Build Your Doctor Discussion Guide Get the Doctor Discussion Guide Next Section: Tools & Resources Also in this section: Taking CAPLYTA Common Side Effects Terms of Use Privacy Policy Cookie Policy Contact Us References ITCI Corporate Site Sitemap Your Privacy Choices AdChoices Opt-Out © Johnson & Johnson and its affiliates 2025. CAPLYTA and LET IN THE LYTE are trademarks of Johnson & Johnson and its affiliates. Trademarks listed are the property of their respective owners. 11/25 US-CAP-2500312